The Early Rheumatoid Arthritis Study
The primary aim of ERAS was to recruit and follow at least 1000 early RA patients receiving conventional therapies in ordinary clinical settings for a minimum ten years. The cohort would be used to develop prognostic factors for clinical, functional and radiological outcomes, and to compare long-term outcomes with future therapies.
The link address is: http://www.nwtrag.com/eras/
BSR Statement on Adalimumab for Rhematoid Arthritis